Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Return on Invested Capital (ROIC) | 15.9% | 18.6% | 19.1% | 18.9% | 26.6% | 32.8% | 40.6% | 44.3% | 55.3% | 58.8% | 59.9% | 80.9% | 66.2% | 56.0% | 49.2% | 47.6% | 40.5% | 34.8% | 36.0% | 39.1% |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month Return on Invested Capital (ROIC) is 42.9%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Return on Invested Capital (ROIC) for Novo Nordisk A/S have been 35.2% over the past three years, and 39.0% over the past five years.
As of today, Novo Nordisk A/S's Return on Invested Capital (ROIC) is 42.9%, which is higher than industry median of (123.1%). It indicates that Novo Nordisk A/S's Return on Invested Capital (ROIC) is Good.